Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation
Description:
In our Randomized controlled, double blind study involving 30 subjects in two groups; the
investigators compared the safety, efficacy and quality of using intrathecal hyperbaric
bupivacaine 0.5% and hyperbaric bupivacaine 0.5% with clonidine 1µg/kg in paediatric patients
undergoing surgeries below T8 dermatome.
American Society of Anesthesiologists (ASA) Grade I patients aged between 3-10 years were
scheduled for the surgeries below T8 dermatome up to two hrs duration. The patients were
randomly allocated in – Group A-who received 0.5%of hyperbaric Bupivacaine 0.4mg/kg for 5
to15 kg or 0.3 mg/kg for more than 15 kg intrathecally.
Group B-who received 0.5%of hyperbaric Bupivacaine 0.4mg/kg for 5 to15 kg or 0.3 mg/kg for
more than 15 kg and 1µg/kg preservative free clonidine intrathecally.
The patients studied across the group did not vary much with respect to age, weight and sex
distribution.
Condition:
Pediatric Spinal Anesthesia
Treatment:
Start Date:
November 2009
Sponsor:
ACPM Medical College
For More Information:
https://clinicaltrials.gov/show/NCT01661803
